However, in the context of tumor metabolic reprogramming and core oncogenic mutations, taurine assumes unique roles in the tumor microenvironment (16).Tumor cells overexpress SLC6A6 to uptake taurine, leading to reduced taurine levels in CD8+ T cells. This evidence concerns the gene SLC6A6 and neoplasm.